Transgenomic's Unattributed VC - II Round

Transgenomic raised a round of funding on October 05, 2005.

Transgenomic (NASDAQ:TBIO) is a global biotechnology company that advances personalized medicine in oncology and inherited diseases via its products and services for automated high-sensitivity genetic…

Articles about Transgenomic's Unattributed VC - II Round: